We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ATC
701
Adirondack Trust Company
New York
$26K +$26K +668 New
ACM
702
Antonetti Capital Management
Florida
$26K +$26K +668 New
ECAM
703
East Coast Asset Management
Massachusetts
$24K +$23.6K +605 New
RIM
704
Ranger International Management
Illinois
$23K +$22.8K +585 New
SFPIA
705
Stevens First Principles Investment Advisors
California
$22K +$21.8K +560 New
AWMS
706
Advocacy Wealth Management Services
Georgia
$20K +$19.5K +500 New
RBC
707
Ronald Blue & Co
Georgia
$18K +$17.7K +455 New
CFSG
708
Community Financial Services Group
Vermont
$18K +$18.1K +465 New
FQ
709
First Quadrant
California
$17K +$16.6K +425 New
CFS
710
Community Financial System
New York
$16K +$15.6K +400 New
DAM
711
Delta Asset Management
Tennessee
$16K +$15.6K +400 New
IRS
712
Invictus RG (Singapore)
Singapore
$16K +$15.6K +400 New
MCM
713
Manchester Capital Management
Vermont
$15K +$14.6K +376 New
FHA
714
First Horizon Advisors
Tennessee
$14K +$13.6K +349 New
ST
715
Smithfield Trust
Pennsylvania
$14K +$14K +359 New
HCM
716
Highlander Capital Management
New Jersey
$13.9K +$13.8K +354 New
CAW
717
Cornerstone Advisors (Washington)
Washington
$13K +$12.4K +319 New
ARMC
718
American Research & Management Company
Massachusetts
$13K +$12.9K +330 New
DBT
719
Dubuque Bank & Trust
Iowa
$13K +$13.3K +341 New
IWC
720
Integrated Wealth Counsel
California
$12K +$11.7K +300 New
MA
721
MCF Advisors
Kentucky
$10K +$7.01K +180 New
PMFA
722
Plante Moran Financial Advisors
Michigan
$10K +$9.74K +250 New
BKBG
723
BHF Kleinwort Benson Group
Belgium
$9K +$8.37K +215 New
BCI
724
Brinker Capital Investments
Pennsylvania
$8K +$7.79K +200 New
First Eagle Investment Management
725
First Eagle Investment Management
New York
$8K +$7.79K +200 New
26 27 28
29
30

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.